hydroxyproline has been researched along with technetium tc 99m pyrophosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griffith, JW; Reeves, WC; Whitesell, L; Wood, MA | 1 |
| Bergmann, P; Fuss, M; Manicourt, D; Martin, P; Schoutens, A; Verbanck, M | 1 |
1 review(s) available for hydroxyproline and technetium tc 99m pyrophosphate
| Article | Year |
|---|---|
Exacerbation of doxorubicin cardiotoxicity by digoxin administration in an experimental rabbit model.
Topics: Animals; Digoxin; Diphosphates; Doxorubicin; Drug Interactions; Heart; Hydroxyproline; Male; Myocardium; Rabbits; Technetium; Technetium Tc 99m Pyrophosphate | 1990 |
1 other study(ies) available for hydroxyproline and technetium tc 99m pyrophosphate
| Article | Year |
|---|---|
Whole body and regional retention of 99mTc-labeled pyrophosphate at 24 hours: physiological basis of the method for assessing the metabolism of bone in disease.
Topics: Adolescent; Adult; Aged; Aging; Arthritis, Rheumatoid; Bone and Bones; Bone Diseases; Child; Child, Preschool; Diphosphates; Female; Glomerular Filtration Rate; Humans; Hydroxyproline; Male; Middle Aged; Technetium; Technetium Tc 99m Pyrophosphate | 1983 |